您的购物车当前为空
别名 HS-38, HS 38
HS38 是一种特异性的 ATP 竞争性 DAPK 抑制剂,对 DAPK1、PIM3 和 ZIPK 的 Kds 分别为 300 nM、200 nM 和 280 nM。 HS38 可用于平滑肌相关疾病的研究。


为众多的药物研发团队赋能,
让新药发现更简单!
HS38 是一种特异性的 ATP 竞争性 DAPK 抑制剂,对 DAPK1、PIM3 和 ZIPK 的 Kds 分别为 300 nM、200 nM 和 280 nM。 HS38 可用于平滑肌相关疾病的研究。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 196 | In Stock | |
| 5 mg | ¥ 455 | In Stock | |
| 10 mg | ¥ 672 | In Stock | |
| 25 mg | ¥ 1,330 | In Stock | |
| 50 mg | ¥ 2,160 | In Stock | |
| 100 mg | ¥ 3,460 | In Stock | |
| 200 mg | ¥ 4,930 | In Stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 490 | In Stock |
HS38 相关产品
| 产品描述 | HS38 is a specific and ATP-competitive DAPK inhibitor with Kds of 300 nM, 200 nM, and 280 nM for DAPK1, PIM3, and ZIPK. HS38 can be used in studies about smooth muscle-related disorders. |
| 靶点活性 | DAPK1:IC50 : 200 nM, ZIPK:280 nM (Kd), Pim3:200 nM (Kd), DAPK1:300 nM (Kd), DAPK2:79 nM (Kd) |
| 体外活性 | HS38 shows a Kd of 79 nM for DAPK2. In human aortic SM cells, HS38 reduces relative RLC20 phosphorylation in both the basal and S1P-activated states. In Ca2+-sensitized rabbit ileum, HS38 reduces the contractile force, MYPT1 phosphorylation, and RLC20 phosphorylation[1]. |
| 别名 | HS-38, HS 38 |
| 分子量 | 349.8 |
| 分子式 | C14H12ClN5O2S |
| CAS No. | 1030203-81-6 |
| Smiles | CC(Sc1nc2n(ncc2c(=O)[nH]1)-c1cccc(Cl)c1)C(N)=O |
| 密度 | 1.65 g/cm3 (Predicted) |
| 颜色 | White |
| 物理性状 | Solid |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||
| 溶解度信息 | DMSO: 6.4 mg/mL (18.4 mM), Sonication is recommended. | ||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||
DMSO
| |||||||||||||||||||||
评论内容